Can Robots Improve Testing Capacity for SARS-CoV-2?


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
12 08 2020
Historique:
received: 13 05 2020
accepted: 22 07 2020
revised: 12 07 2020
pubmed: 1 8 2020
medline: 22 8 2020
entrez: 1 8 2020
Statut: epublish

Résumé

There is currently increasing interest internationally in deploying robotic applications for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, as these can help to reduce the risk of transmission of the virus to health care staff and patients. We provide an overview of key recent developments in this area. We argue that, although there is some potential for deploying robots to help with SARS-CoV-2 testing, the potential of patient-facing applications is likely to be limited. This is due to the high costs associated with patient-facing functionality, and risks of potentially adverse impacts on health care staff work practices and patient interactions. In contrast, back-end laboratory-based robots dealing with sample extraction and amplification, that effectively integrate with established processes, software, and interfaces to process samples, are much more likely to result in safety and efficiency gains. Consideration should therefore be given to deploying these at scale.

Identifiants

pubmed: 32735547
pii: v22i8e20169
doi: 10.2196/20169
pmc: PMC7450371
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20169

Subventions

Organisme : Chief Scientist Office
ID : PDF/15/04
Pays : United Kingdom

Informations de copyright

©Kathrin Cresswell, Sandeep Ramalingam, Aziz Sheikh. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 12.08.2020.

Références

Int J Med Inform. 2005 Aug;74(7-8):519-26
pubmed: 16043081
J Lab Autom. 2012 Jun;17(3):169-85
pubmed: 22357568
JAMA. 2020 Mar 3;:
pubmed: 32125371
J Med Internet Res. 2018 Jul 04;20(7):e10410
pubmed: 29973336
JAMA. 2020 Feb 24;:
pubmed: 32091533
Nat Biotechnol. 2020 May;38(5):515-518
pubmed: 32203294
PLoS One. 2020 Jun 12;15(6):e0234682
pubmed: 32530929
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510

Auteurs

Kathrin Cresswell (K)

The University of Edinburgh, Edinburgh, United Kingdom.

Sandeep Ramalingam (S)

The University of Edinburgh, Edinburgh, United Kingdom.

Aziz Sheikh (A)

The University of Edinburgh, Edinburgh, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH